Spanish pharma aims to churn out new products to offset public cuts

Pharmaceutical companies in Spain aim to speed up the marketing of new products to offset public cuts, Spanish auditing company KPMG study says.

According to a survey of company executives, which was published by KPMG Spain on 3 November, 70 per cent of Spanish pharma companies say they aim to speed up the introduction of products on the market to beat the crisis and increase their income.